Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Aaron Galaznik
Bioengineering | Free Full-Text | Remote Symptom Alerts and Patient-Reported Outcomes (PROS) in Real-World Breast Cancer Practice: Innovative Data to Derive Symptom Burden and Quality of Life
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
10.28.20 -- 4 Practical Ways To Improve The Patient Experience In Clinical Trials
By Adrianne Phillips and Lyn Agostinelli, Halloran Consulting Group, Inc. Stakeholders have recognized the need for patients and advocates to have a seat at the table and be the central focus in enterprise approaches, commercialization, and research and development. How can we gather as much data in as few studies as possible? And, in doing this, how can we acknowledge the impact that taking part in a trial has on the patients we are working to help? By Luther T.
Economic burden and treatment patterns for patients with diffuse large B-cell lymphoma and follicular lymphoma in the USA
Metrics Downloaded 81 times History Received 12 September 2018 Accepted 14 January 2019 Published online 11 March 2019 Published in print April 2019 Information © 2019 Future Medicine Ltd KeywordsFinancial & competing interests disclosure CV Asche and J Ren are consultants for Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, MA, USA.
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username Username or Email: If the address matches an existing account you will receive an email with instructions to retrieve your username
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username Username or Email: If the address matches an existing account you will receive an email with instructions to retrieve your username
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username Username or Email: If the address matches an existing account you will receive an email with instructions to retrieve your username
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username Username or Email: If the address matches an existing account you will receive an email with instructions to retrieve your username
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username Username or Email: If the address matches an existing account you will receive an email with instructions to retrieve your username
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username Username or Email: If the address matches an existing account you will receive an email with instructions to retrieve your username
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username Username or Email: If the address matches an existing account you will receive an email with instructions to retrieve your username
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username If the address matches an existing account you will receive an email with instructions to retrieve your username
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username If the address matches an existing account you will receive an email with instructions to retrieve your username
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username If the address matches an existing account you will receive an email with instructions to retrieve your username
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username If the address matches an existing account you will receive an email with instructions to retrieve your username
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username If the address matches an existing account you will receive an email with instructions to retrieve your username
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username If the address matches an existing account you will receive an email with instructions to retrieve your username
Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username If the address matches an existing account you will receive an email with instructions to retrieve your username
Gastrointestinal adverse events with combination of checkpoint inhibitors in advanced melanoma: a systematic review
Introduction: Immunotherapies, including checkpoint inhibitors (CIs) such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed death-1 (PD-1) inhibitors, are revolutionizing the treatment of advanced melanoma. Combining CTLA-4 and PD-1 inhibitors provides additional clinical benefit compared with single agents alone. However, combination therapy can increase the incidence of gastrointestinal adverse events (GI AEs).
Relationship between age and erectile dysfunction diagnosis or treatment using real-world observational data in the USA
With self-reporting of erectile dysfunction (ED) in population-based surveys, men with ED may not represent men who are bothered sufficiently to seek an ED diagnosis and treatment. We used real-world observational data to assess: 1) the prevalence of ED diagnosis or treatment by age subgroups; and 2) the relationship of age with ED diagnosis or treatment after controlling for ED-related comorbidities in the USA.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Aaron
Contact Aaron, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack